Home > News > Q Chip seals deal with leading biotech firm
December 28th, 2004
Q Chip seals deal with leading biotech firm
Abstract:
Cardiff-based Q Chip has agreed the joint venture with FTSE techMark 100-listed Biocompatibles International, a medical device company which is focused on the treatment of cardiovascular disease, cancer and benign tumours.
The Welsh company possesses technology which enables the production of uniform particles at a molecular level. It uses tiny capillaries etched in wafers to precisely create micro and nanoparticles.
Source:
icwales
Bookmark:
Q Chip
Biocompatibles International
Investments/IPO's/Splits
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanostart-holding New Asia Investments invests in breakthrough water projects May 13th, 2013
Nanomedicine
Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013
Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013